Depressive Symptoms Among Amphetamine and Cocaine Users Before and After Substance Abuse Treatment

Published in: Psychology of Addictive Behaviors, v. 16, no. 4, Dec. 2002, p. 333-337

Posted on on January 01, 2002

by Kara Riehman, Martin Y. Iguchi, M. Douglas Anglin

Read More

Access further information on this document at

This article was published outside of RAND. The full text of the article can be found at the link above.

This study examined whether higher rates of depressive symptoms among amphetamine compared with cocaine users result from amphetamine use itself, polydrug use, or experiencing a major lifetime depressive episode and whether depressive symptoms among amphetamine users are more likely to persist 12 months after treatment. The association between amphetamine use and depressive symptoms disappears when controlling for polydrug use and lifetime major depressive episode. Polydrug use and lifetime depressive episode are significantly related to depressive symptoms in the year preceding treatment. Amphetamine use at intake does not predict depressive symptoms among individuals who are abstinent at follow-up, and amphetamine users are no more likely than cocaine users to report depression at a 12-month follow-up.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.